Nyu Langone Hospitals (Formerly Nyu Hospitals Center)
Based in NY
🤖
AI Overview
With $928K in lobbying spend across 37 quarterly filings, Nyu Langone Hospitals (Formerly Nyu Hospitals Center) is an active lobbying client. Their lobbying covers 12 issue areas. Active from 2018 to 2025.
$928K
Total Spend
8
Years Active
1
Firms Hired
3
Lobbyists Deployed
12
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $80K |
| 2019 | $76K |
| 2020 | $116K |
| 2021 | $116K |
| 2022 | $80K |
| 2023 | $100K |
| 2024 | $150K |
| 2025 | $210K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Budget/Appropriations, Medicare/Medicaid, Disaster Planning, Health Issues, Transportation and 7 more
- •Funding for public-private partnership demo, High-Acuity Trauma Centers, Combating Opioid Abuse, Community Health Centers
- •The Resident Physician Shortage Act (H.R. 226), Medicare DSH payments, Children's Health Insurance Program
- •Saline shortages and recovery in Puerto Rico
- •Right to Try
- •The Resident Physician Shortage Act (H.R.2267); 340B drug pricing program
Related Analysis
Related Investigations
The 22,000% ROI
When lobbying spending yields outsized returns.
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
The Crypto Lobbying Explosion
How crypto went from zero to massive lobbying presence.
Big Tech's $150M Lobbying War
Tech giants battle over AI, antitrust, privacy, and trade.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.